Le Centre hospitalier de Périgueux, ayant comme sigle CHP, est un centre hospitalier français situé à Périgueux, dans le département de la Dordogne, en région Nouvelle-Aquitaine.

During the past decade, Centre Hospitalier de Périgueux conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 4 clinical trials were completed, i.e. on average, 10.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 3 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Périgueux" #1 sponsor was "University Hospital, Bordeaux" with 5 trials, followed by "Groupe Francophone des Myelodysplasies" with 3 trials sponsored, "Intergroupe Francophone du Myelome" with 3 trials sponsored, "Nantes University Hospital" with 3 trials sponsored and "Rennes University Hospital" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Périgueux" #1 collaborator was "Sanofi" with 3 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Périgueux" are "Multiple Myeloma" (5 trials), "Venous Thromboembolism" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Colorectal Cancer" (2 trials) and "Myelodysplastic Syndromes" (2 trials). Many other conditions were trialed in "Centre Hospitalier de Périgueux" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Périgueux" are "Drug" (28 trials), "Procedure" (8 trials), "Device" (5 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cisplatin" (2 trials), "ASCT" (1 trials), "Amoxicillin - clavulanic acid" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Périgueux" are 56 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Périgueux". 1 are not yet recruiting, 12 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Centre Hospitalier de Périgueux, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Périgueux, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

Centre Hospitalier de Périgueux has several departments that took part in Clinical trials: "Service de Pneumologie-Allergologie; Centre Hospitalier Général" - 2 trials, "Unité de Recherche Clinique - CH Périgueux" - 2 trials